Hyponatraemia, mortality and haemodialysis: An unexplained association;Hiponatremia, mortalidad y hemodiálisis: una asociación no explicada

Nefrologia

Volumn 36, Issue 1, 2016, Pages 42-50

  Pérez García, Rafael ^a   Palomares, Inés ^b   Merello, José Ignacio ^b   Ramos, Rosa ^b   Maduell, Francisco ^c   Molina, Manolo ^d   Aljama, Pedro ^e   Marcelli, Daniele ^f  

^a HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^b NephroCare   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARIO SANTA LUCÍA   (Spain)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f FRESENIUS MEDICAL CARE   (Germany)

Author keywords

Diabetes; Haemodialysis; Hyponatraemia; Mortality; Serum sodium

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; SODIUM;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY WEIGHT; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DESCRIPTIVE RESEARCH; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENDER; GLUCOSE BLOOD LEVEL; HEMODIALYSIS PATIENT; HUMAN; HYDRATION; HYPERVOLEMIA; HYPONATREMIA; LEAN TISSUE INDEX; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY RISK; MUSCULOSKELETAL SYSTEM PARAMETERS; OBSERVATIONAL STUDY; PROGNOSIS; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; ULTRAFILTRATION; VASCULAR ACCESS; WEIGHT GAIN; AGED; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; HEMODIALYSIS; MORTALITY;

AGED; COHORT STUDIES; CREATININE; DIABETES MELLITUS; FEMALE; HUMANS; HYPONATREMIA; KIDNEY FAILURE, CHRONIC; MALE; PROGNOSIS; RENAL DIALYSIS; SODIUM;

EID: 85008939222     PISSN: None     EISSN: 20132514     Source Type: Journal    
DOI: 10.1016/j.nefroe.2016.02.005     Document Type: Article

References (31)

1. 1 Nair, V., Niederman, M.S., Masani, N., Fishbane, S., Hyponatremia in community-acquired pneumonia. Am J Nephrol 27 (2007), 184–190.
2. 2 Waikar, S.S., Mount, D.B., Curhan, G.C., Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 122 (2009), 857–865.
3. 3 Sato, N., Gheorghiade, M., Kajimoto, K., Munakata, R., Minami, Y., Mizuno, M., et al. ATTEND Investigators. Hyponatremia and in-hospital mortality in patients admitted for heart failure (from the ATTEND registry). Am J Cardiol 111 (2013), 1019–1025.
4. 4 Kim, W.R., Biggins, S.W., Kremers, W.K., Wiesner, R.H., Kamath, P.S., Benson, J.T., et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 359 (2008), 1018–1026.
5. 5 Milo-Cotter, O., Cotter, G., Weatherley, B.D., Adams, K.F., Kaluski, E., Uriel, N., et al. Hyponatraemia in acute heart failure is a marker of increased mortality but not when associated with hyperglycaemia. Eur J Heart Fail 10 (2008), 196–200.
6. 6 Moritz, M.L., Ayus, J.C., The pathophysiology and treatment of hyponatraemic encephalopathy: an update. Nephrol Dial Transplant 18 (2003), 2486–2491.
7. 7 Waikar, S.S., Curhan, G.C., Brunelli, S.M., Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am J Med 124 (2011), 77–84.
8. 8 Hecking, M., Karaboyas, A., Saran, R., Sen, A., Hörl, W.H., Pisoni, R.L., et al. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 59 (2012), 238–248.
9. 9 Hecking, M., Karaboyas, A., Saran, R., Sen, A., Inaba, M., et al. Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol 7 (2012), 92–100.
10. 10 Mc Causland, F.R., Brunelli, S.M., Waikar, S.S., Dialysate sodium, serum sodium and mortality in maintenance hemodialysis. Nephrol Dial Transplant 27 (2012), 1613–1618.
11. 11 Sahin, O., Asci, G., Kircelli, F., Yilmaz, M., Duman, S., et al. The impact of low serum sodium level on mortality depends on glycemic control. Eur J Clin Invest 42 (2012), 534–540.
12. 12 Nigwekar, S.U., Wenger, J., Thadhani, R., Bhan, I., Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study. Am J Kidney Dis 62 (2013), 755–762.
13. 13 Renneboog, B., Musch, W., Vandemergel, X., Manto, M.U., Decaux, G., Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med, 119, 2006, 71 e1–8.
14. 14 Pérez-García, R., Martín-Malo, A., Fort, J., Cuevas, X., Lladós, F., Lozano, J., et al. ANSWER study. Baseline characteristics of an incident haemodialysis population in Spain: Results from ANSWER – a multicentre, prospective, observational cohort study. Nephrol Dial Transplant 24 (2009), 578–588.
15. 15 Marcelli, D., Kirchgessner, J., Amato, C., Steil, H., Mitteregger, A., Moscardò, V., et al. EuClid (European Clinical Database): a database comparing different realities. J Nephrol 14:Suppl. 4 (2001), S94–S100.
16. 16 Steil, H., Amato, C., Carioni, C., Kirchgessner, J., Marcelli, D., Mitteregger, A., et al. EuClid – a medical registry. Methods Inf Med 43 (2004), 83–88.
17. ® database: results from years 2009–2010. Nefrologia 32 (2012), 743–753.
18. 18 Maduell, F., Ramos, R., Palomares, I., Martín-Malo, A., Molina, M., Bustamante, J., et al. Impact of targeting Kt instead of Kt/V. Nephrol Dial Transplant 28 (2013), 2595–2603.
19. 19 Cuevas, X., García, F., Martín-Malo, A., Fort, J., Lladós, F., Lozano, J., et al. Risk factors associated with cardiovascular morbidity and mortality in Spanish incident hemodialysis patients: two-year results from the ANSWER study. Blood Purif 33 (2011), 21–29.
20. 20 Peixoto, A.J., Santos, S.F., How should the predialysis plasma sodium level be interpreted in hemodialysis patients?. Semin Dial 24 (2011), 409–411.
21. 21 Keen, M.L., Gotch, F.A., The association of the sodium “setpoint” to interdialytic weight gain and blood pressure in hemodialysis patients. Int J Artif Organs 30 (2007), 971–979.
22. 22 Maduell, F., Navarro, V., Valoración de la ingesta de sal en hemodiálisis. Nefrologia 21 (2001), 71–77.
23. 23 Albalate, M., de Sequera, P., Pérez-García, R., Corchete, E., Talaván, R.T., Ruiz-Álvarez, M.J., et al. Set-point de sodio en hemodiálisis: mito o realidad. Nefrología 33 (2013), 808–815.
24. 24 Thomson, B.K., Huang, S.H., Chan, C.T., House, A.A., Lindsay, R.M., Plasma sodium setpoint: is it constant or changed by hemodialysis prescription?. ASAIO J 59 (2013), 497–504.
25. 25 Raimann, J., Thijssen, S., Usvyat, L., Levin, N., Kotanko, P., Sodium alignment in clinical practice. Implementation and implications. Sem Dial 24 (2011), 587–589.
26. 26 Hecking, M., Karaboyas, A., Antlanger, M., Saran, R., Wizemann, V., Chazot, C., et al. Significance of interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol 38 (2013), 78–90.
27. 27 López-Gómez, J.M., Villaverde, M., Jofre, R., Rodriguez-Benítez, P., Pérez-García, R., Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int Suppl 93 (2005), S63–S68.
28. 28 Graziani, G., Badalamenti, S., Del Bo, A., Marabini, M., Gazzano, G., Como, G., et al. Abnormal hemodynamics and elevated angiotensin II plasma levels in polydipsic patients on regular hemodialysis treatment. Kidney Int 44 (1993), 107–114.
29. 29 Martinez-Vea, A., García, C., Gaya, J., Rivera, F., Oliver, J.A., Abnormalities of thirst regulation in patients with chronic renal failure on hemodialysis. Am J Nephrol 12 (1992), 73–79.
30. 30 Sung, J.M., Kuo, S.C., Guo, H.R., Chuang, S.F., Lee, S.Y., Huang, J.J., Decreased salivary flow rate as a dipsogenic factor in hemodialysis patients: evidence from an observational study and a pilocarpine clinical trial. J Am Soc Nephrol 16 (2005), 3418–3429.
31. 31 Samuel-Variath, R., Chan, R., Michelis, M.F., Evaluation of plasma osmolality and hormone responses in elderly chronic hemodialysis patients with excessive interdialytic weight gain. Geriatr Nephrol Urol 7 (1997), 131–135.